- Home
- Cognitive Health & Nootropics
- Modafinil
Modafinil
Modafinil · Wakefulness-promoting agent
A wakefulness-promoting medicine used for excessive sleepiness associated with narcolepsy.
- Partner pharmacy
- Personal assistance
- Discreet delivery
- Active ingredientModafinil
- AdministrationOral
- Legal statusControlled in some markets (Schedule IV in the US)
Shipping & Delivery
- Normally dispatched within 24 hours of payment confirmation.
- UPS Express · C$25 · Approx. 7–9 business days
- Registered Mail · C$15 · Approx. 14–20 business days
What Modafinil is
Modafinil is a wakefulness-promoting agent. In the UK and EU it is authorized for excessive sleepiness associated with narcolepsy. It is a controlled substance in some markets, including the United States.
Suitability and dosing are decided by a prescriber on the basis of the approved product information.
Wakefulness, not stimulation in the usual sense
Modafinil promotes wakefulness. Its exact mechanism is not fully understood; it acts on the dopamine transporter and on several brain systems that regulate sleep and waking.
In the UK and the EU it is authorized only for excessive sleepiness associated with narcolepsy. In 2010 the European Medicines Agency restricted its use to this indication after reviewing the benefits and risks.1
Side effects and warnings
Commonly reported side effects include:
- Headache, nervousness and difficulty sleeping
- Palpitations and a fast heartbeat
- Reduced effectiveness of hormonal contraceptives
Product information
Common questions
Do I need a prescription?
Modafinil is a prescription-only medicine. After your request, the partner pharmacy verifies whether and how supply is possible, for example through an existing prescription or an assessment by an independent doctor where permitted.
Is it authorized to improve concentration?
No. In the UK and the EU it is authorized only for excessive sleepiness associated with narcolepsy. Other uses are not authorized.
Does it affect contraception?
Yes. Modafinil can make hormonal contraceptives less effective; the product information describes the alternative or additional methods needed.
Do I pay when I send a request?
No. Payment is arranged individually with customer service once your request has been reviewed and can proceed.
Sources
- European Medicines Agency. European Medicines Agency recommends restricting the use of modafinil. Press release, 22 July 2010.
- Modafinil: Summary of Product Characteristics.